[Email id of designated official for the purpose of grievance redressal]
Unaudited Financial Results for the Quarter ended 30th September, 2007 |
|||||
---|---|---|---|---|---|
(RS. IN LACS) |
|||||
PARTICULARS | Unaudited Qtr. ended 30.09.07 |
Unaudited Qtr. ended 30.09.06 |
Unaudited half Year ended 30.09.07 |
Unaudited half Year ended year30.09.06 |
Audited year ended 31.03.07 |
INCOME FROM OPERATIONS | 12244.97 |
9100.61 |
23314.5 |
17443.07 |
37768.84 |
OTHER INCOME | 28.72 |
12.11 |
45.17 |
23.71 |
203.7 |
TOTAL INCOME | 12273.69 |
9112.72 |
23359.67 |
17466.78 |
37972.54 |
TOTAL EXPENDITURE | 10681.25 |
7912.94 |
20319.56 |
15237.42 |
33009.18 |
DECREASE IN STOCK IN TRADE | -1452.45 |
-163.73 |
237.84 |
394.7 |
-5043.75 |
CONSUMPTION OF RAW MATERIAL | 10452.97 |
6902.06 |
16870.99 |
12464.2 |
32523.35 |
COST OF SALES | 9000.52 |
6738.33 |
17108.83 |
12858.90 |
27479.60 |
STAFF COST | 411.36 |
302.30 |
789.03 |
592.17 |
1451.28 |
OTHER EXPENSES | 1269.37 |
872.31 |
2421.7 |
1786.35 |
4078.30 |
INTEREST | 619.56 |
383.33 |
1177.49 |
713.43 |
1765.21 |
DEPRECIATION | 110.00 |
69.20 |
220.00 |
137.35 |
334.25 |
PROFIT BEFORE TAX | 862.88 |
747.25 |
1642.62 |
1378.58 |
2863.90 |
PROVISION FOR TAX(INCL.FBT) | 107.76 |
91.68 |
206.1 |
170.36 |
366355.82 |
PROVISION FOR DEFFERED TAX | 862.88 |
747.25 |
1642.62 |
1378.58 |
2863.90 |
NET PROFIT | 655.12 |
589.42 |
1186.52 |
1089.92 |
2085.18 |
SHARE CAPITAL | 743.57 |
743.57 |
743.57 |
743.57 |
743.57 |
RESERVE EXCLUDING REVALUATION RESERVE | |||||
E.P.S.(Rs.) RATE/SHARE Rs.2/- | 1.76 |
1.59 |
3.19 |
2.93 |
5.61 |
NON-PROMOTERS SHAREHOLDING |
|||||
No. OF SHARES | 23931582 |
24056575 |
23931582 |
24056475 |
23985890 |
% AGE OF TOTAL HOLDING | 64.37 |
64.70 |
64.37 |
64.70 |
64.51 |
Notes:- |
|||||
1.The commercial production of soft gelatine capsule at company's Unit IV at Baddi (H.P.) has commenced. 2. During the quarter under review, the Income of the company has grown by 35% and Profit before tax has shown an increase of 15% as compared to the same period in the previous year. 3.The company is exclusively in the pharamaceutical business segment only. 4.Information on investor's Complaints for the quarter: Opening: nil, Received: 6, Pending:Nil 5. The above results were taken on record by the Audit Committee and Board of Directors at their respective meetings held on 29th October 2007
|
|||||
On behalf of the
Board
|
|||||
Dated: 29th October 2007 | (S.R. Mehta) |
||||
Place: Chandigarh | Managing Director |
||||